Treatment Options for Sleep Dysfunction in Parkinson’s Disease

被引:0
作者
Mary Ann Thenganatt
Steven J. Frucht
机构
[1] Mount Sinai School of Medicine,Department of Neurology
[2] Columbia University,Department of Neurology, College of Physicians and Surgeons
来源
Current Treatment Options in Neurology | 2011年 / 13卷
关键词
Levodopa; Deep Brain Stimulation; Dopamine Agonist; Modafinil; Pramipexole;
D O I
暂无
中图分类号
学科分类号
摘要
Sleep disturbance is an important feature of Parkinson’s disease (PD) that deserves clinical attention. Various disorders need to be considered and treatment should be customized to the patient’s specific symptoms and lifestyle. Evaluation of a PD patient complaining of difficulty sleeping begins with a detailed history from the patient and bed partner about the specific problem the patient is experiencing. It is important to inquire about difficulties with sleep onset, frequent awakenings, increased movements during sleep, acting out dreams, uncomfortable motor symptoms, disordered breathing, and nocturia. Current medications should be reviewed to determine whether the recent addition of a drug or a change in dose may be contributing to sleep difficulties, and one should ask about daytime sleepiness, frequent daytime naps, and sleep hygiene in the evening that can contribute to problems sleeping at night. The goal of therapy is to restore quality nighttime sleep without excessive daytime sedation and to improve the patient’s daily mental and physical function and overall quality of life.
引用
收藏
页码:473 / 487
页数:14
相关论文
共 102 条
[1]  
Gjerstad MD(2007)Insomnia in Parkinson’s disease: frequency and progression over time J Neurol Neurosurg Psychiatry 78 476-479
[2]  
Tandberg E(1998)A community-based study of sleep disorders in patients with Parkinson’s disease Mov Disord 13 895-899
[3]  
Larsen JP(2011)Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease J Neurol 258 494-499
[4]  
Karlsen K(2002)Sleep disorders in Parkinson’s disease Mov Disord 17 775-781
[5]  
Gómez-Esteban JC(2010)British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders J Psychopharmacol 24 1577-1601
[6]  
Tijero B(2002)The prevalence of sleep disorders in patients with Parkinson’s disease. A self-reported, community-based survey Sleep Med 3 147-149
[7]  
Somme J(2002)REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease Neurology 59 585-589
[8]  
Kumar S(1998)Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease Neurology 51 526-529
[9]  
Bhatia M(2010)REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century Neurology 75 494-499
[10]  
Behari M(2010)Best practice guide for the treatment of REM sleep behavior disorder (RBD) J Clin Sleep Med 6 85-95